POOR OUTCOMES OF NPM1 MUTATED AML IN BRAZIL REGARDLESS OF TRADITIONAL RISK FACTORS AND RECENT INCORPORATION OF MOLECULAR MONITORING MVA Azevedo; FR Mendes; RCB Melo; L Nardinelli; I Bendit; EDRP Velloso; V Rocha; EM Rego; WF Silva;

CLONAL EVOLUTION TO ACUTE MYELOID LEUKEMIA FOUR YEARS AFTER ALEMTUZUMAB AND CYCLOSPORINE IMMUNOSUPPRESSION IN A PATIENT WITH VERY SEVERE APLASTIC ANEMIA LP Cantarino; WA Poles; LR Soares; PEM Flores; RS Martins; PMC Silva; CB Prato; MEAJ Carvalho; GMC Silva; CAR Silva;

HISTIOCITOSE DE CÉLULAS AZUL MARINHO ¿ RELATO DE CASO PEM Flores; AF Sandes; CB Prato; LP Cantarino; PMC Silva; GMC Silva; TAS Pereira; WA Poles; RS Martins; SMCBP Jesus;